Download Files:
PDE7-IN-3
SKU
HY-100326-10 mg
Category Reference compound
Tags Inflammation/Immunology; Neurological Disease, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
$220 – $2,070
Products Details
Product Description
– Pde7-in-3 (example 2) is an inhibitor of the phosphodiesterase PDE7 with potential analgesic activity. PDE7-IN-3 can be used to study inflammatory, neuropathic, visceral and nociceptive pain[1].
Web ID
– HY-100326
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C18H21ClN2O4
References
– [1]Cox Peter, et al. Use of combinations of PDE7 inhibitors and alpha-2-delta ligands for the treatment of neuropathic pain. World Intellectual Property Organization, WO2006092692 A1. 2006-09-08.
CAS Number
– 908570-13-8
Molecular Weight
– 364.82
Compound Purity
– 99.24
SMILES
– O=C1NC2(CCCCC2)C(C(N1)=C3Cl)=C(C=C3)O[C@@H](C4)C[C@H]4C(O)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Phosphodiesterase (PDE)
Isoform
– PDE7
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.